B of A Securities Upgrades Core Laboratories to Neutral

B of A Securities analyst Chase Mulvehill upgrades Core Laboratories (NYSE:CLB) from Underperform to Neutral.

B of A Securities analyst Chase Mulvehill upgrades Core Laboratories (NYSE:CLB) from Underperform to Neutral.

Total
0
Shares
Related Posts
Read More

Seagen Highlights First Solid Tumor Data For An ADCETRIS Immunotherapy Combination And Preclinical Data For Novel CD30-Directed Antibody-Drug Conjugate At Society For Immunotherapy Of Cancer Annual Meeting

– Initial Phase 2 data presented for ADCETRIS in combination with immunotherapy pembrolizumab in metastatic non-small cell lung cancer and metastatic cutaneous melanoma –– Preclinical data presented for novel

SGEN